MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $269,089 | -47.5% | 86,839 | -51.8% | 0.00% | – |
| Q2 2023 | $513,003 | -28.9% | 179,987 | -1.8% | 0.00% | – |
| Q1 2023 | $721,806 | +97573.3% | 183,244 | -1.9% | 0.00% | – |
| Q4 2022 | $739 | -99.9% | 186,725 | +154.8% | 0.00% | – |
| Q3 2022 | $673,000 | +50.2% | 73,274 | -2.7% | 0.00% | – |
| Q2 2022 | $448,000 | +12.8% | 75,346 | +22.0% | 0.00% | – |
| Q1 2022 | $397,000 | +15.1% | 61,743 | +17.4% | 0.00% | – |
| Q4 2021 | $345,000 | +32.7% | 52,578 | +15.5% | 0.00% | – |
| Q3 2021 | $260,000 | 0.0% | 45,517 | -3.6% | 0.00% | – |
| Q2 2021 | $260,000 | +17.1% | 47,200 | +23.2% | 0.00% | – |
| Q1 2021 | $222,000 | +48.0% | 38,316 | +71.4% | 0.00% | – |
| Q4 2020 | $150,000 | – | 22,355 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,425,737 | $22,293,000 | 3.44% |
| Lion Point Capital, LP | 1,557,233 | $11,186,000 | 2.46% |
| ACUTA CAPITAL PARTNERS, LLC | 597,026 | $5,487,000 | 2.36% |
| Ikarian Capital, LLC | 855,616 | $7,863,000 | 1.57% |
| GREAT POINT PARTNERS LLC | 674,656 | $6,200,000 | 1.49% |
| Bleichroeder LP | 512,500 | $4,710,000 | 0.98% |
| RTW INVESTMENTS, LP | 4,315,102 | $39,656,000 | 0.91% |
| Novo Holdings A/S | 2,000,000 | $18,380,000 | 0.88% |
| Paradigm Biocapital Advisors LP | 634,211 | $5,828,000 | 0.78% |
| Ikarian Capital, LLC | 338,000 | $3,107,000 | 0.62% |